Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

NAOS

Financiado

Cerrado

a disruptive implantable neurostimulator for the treatment of epilepsy

The objective of this innovation project is to develop a disruptive implantable neurostimulator for the treatment of epilepsy with the goal to place it on the market by 2021. Neurostimulation is a $4.7 billion market and one of t... ver más

30/11/2019

SYNERGIA MEDICAL

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

SYNERGIA MEDICAL No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2019-11-30

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

SYNERGIA MEDICAL

50.00K€ | Lider

BODEGA COOPERATIVA SAN MARTI...

258.01K€ | Participante

Proyectos interesantes

Outer-Ret

Medical Technol...

Electronics

3M€ Cerrado

BES-2017-081603

Medical Technol...

Electronics

93K€ Cerrado

DENECOR

Medical Technol...

Electronics

20M€ Cerrado

MINIGRAPH

Medical Technol...

Electronics

4M€ Cerrado

PLEC2022-009232

Medical Technol...

Electronics

327K€ Cerrado

PRE2021-100189

Medical Technol...

Electronics

101K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 4 meses Fecha Inicio: 2019-07-17
Fecha Fin: 2019-11-30

Líder del proyecto

SYNERGIA MEDICAL No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The objective of this innovation project is to develop a disruptive implantable neurostimulator for the treatment of epilepsy with the goal to place it on the market by 2021. Neurostimulation is a $4.7 billion market and one of the fastest-growing areas of medicine, that has been approved for the treatment of several neurological disorders. Among these, epilepsy is the most frequent nervous system disease. Of the 50 million people suffering from epilepsy, with 3.7 million in Europe, approximately one third of them are resistant to medication but respond well to the neurostimulation. Neurostimulators are small implanted devices stimulating nerves or brain tissue. The innovative aspects of the project are based on a Synergia Medical’s patented concept and consists in replacing wires by optical fibres. The innovation will improve the traditional therapy and brings the main following competitive advantages: - it renders the neurostimulator compatible with magnetic resonance imaging (MRI) diagnosis - it provides a highly tunable stimulation and ultra low power consumption - it improves safety due to electrical isolation and allow for a smaller size implant The main objective of this feasibility study is to complete the business plan by: - completing a market study and refining specifications of the neurostimulator with key opinion leaders in the field of epilepsy; - manufacturing prototypes of neurostimulators to validate stimulation capabilities, low power consumption, compactness, optical chain efficiency and estimate production costs; - refining the development and production planning, including budget and human resources, based on cost estimates and test results; - finalizing the selection of subcontractors involved in the production chain; - filing additional patents and realizing a complete FTO.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores